To get rid of cancer by Antibody drug conjugates

Our antibody drug conjugates combines the powerful cell-killing ability of potent cytotoxic agents with target specificity which represent a potentially new example in treating cancer. It is such an approach, in which the component of antibody provides specificity for a tumor target antigen and the drug confers the cytotoxicity. We have more than a decade of experience in ADC technology and our ADCs at various phases of clinical trials have been shown to be more efficacious. Visit us at: www.gapsos.com